VIVA BIOTECH HOLDINGS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.73 HKD | +15.87% |
|
+23.73% | -30.48% |
| Mar. 28 | Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 18 | Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.38B 329M 2.57B | Sales 2023 | 2.16B 298M 2.33B | Capitalization | 2.04B 283M 2.21B |
|---|---|---|---|---|---|
| Net income 2022 | -528M -73.07M -570M | Net income 2023 | -116M -16.05M -125M | EV / Sales 2022 | 2.15 x |
| Net Debt 2022 | 2.14B 297M 2.31B | Net Debt 2023 | 867M 120M 936M | EV / Sales 2023 | 1.35 x |
| P/E ratio 2022 |
-5.52
x | P/E ratio 2023 |
-6.67
x | Employees | 2,077 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.36% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +15.87% | ||
| 1 week | +23.73% | ||
| Current month | +37.74% | ||
| 1 month | +64.04% | ||
| 3 months | +21.67% | ||
| 6 months | -38.14% | ||
| Current year | -30.48% |
1 week
0.57
0.73
1 month
0.410.73
Current year
0.411.05
1 year
0.412.00
3 years
0.4111.64
5 years
0.4111.64
10 years
0.4111.64
| Managers | Title | Age | Since |
|---|---|---|---|
Ying Wu
FOU | Founder | 60 | 08-08-26 |
Chen Mao
CEO | Chief Executive Officer | 61 | 08-08-26 |
Wei Xiong
DFI | Director of Finance/CFO | 41 | Nov. 30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiang Rong Li
BRD | Director/Board Member | 51 | 17-12-31 |
| - | - | ||
Hai Guang Wang
BRD | Director/Board Member | 60 | 17-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.28% | 4 M€ | -27.92% | ||
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 112 M€ | +5.51% | - | |
| 0.00% | 34 M€ | +4.26% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 0.73 | +15.87% | 6 606 000 |
| 24-05-16 | 0.63 | -1.56% | 5,792,500 |
| 24-05-14 | 0.64 | +6.67% | 3,270,000 |
| 24-05-13 | 0.6 | +1.69% | 3,957,000 |
| 24-05-10 | 0.59 | 0.00% | 1,429,000 |
Delayed Quote Hong Kong S.E., May 17, 2024 at 01:56 am EDT
More quotes
VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Companyâs core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.
Sector
Pharmaceuticals
Calendar
2024-06-25
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.48% | 173M | |
| +32.36% | 694B | |
| +30.77% | 593B | |
| -1.60% | 371B | |
| +20.07% | 331B | |
| +6.04% | 290B | |
| +14.77% | 239B | |
| +9.13% | 209B | |
| -3.97% | 209B | |
| +9.27% | 169B |
- Stock Market
- Equities
- 1873 Stock
